A9577 – Injection, gadobenate dimeglumine (multihance), per ml
HCPCS Level II code · A codes: Transportation, Medical & Surgical Supplies, Miscellaneous & Experimental
HCPCS codeA9577
- Long description
- Injection, gadobenate dimeglumine (multihance), per ml
- Short description
- Inj multihance
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
I1EStandard imaging - nuclear medicine- Added
- January 1, 2008
- Last change
- January 1, 2008 – No change
Frequently asked questions
What is HCPCS code A9577?
A9577 is a HCPCS Level II code for injection, gadobenate dimeglumine (multihance), per ml.
Does Medicare cover A9577?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby A codes
- A9569 – Technetium tc-99m exametazime labeled autologous white blood cells, diagnostic, per study dose
- A9570 – Indium in-111 labeled autologous white blood cells, diagnostic, per study dose
- A9571 – Indium in-111 labeled autologous platelets, diagnostic, per study dose
- A9572 – Indium in-111 pentetreotide, diagnostic, per study dose, up to 6 millicuries
- A9573 – Injection, gadopiclenol, 1 ml
- A9574 – Injection, ferumoxytol, 1 mg
- A9575 – Injection, gadoterate meglumine, 0.1 ml
- A9576 – Injection, gadoteridol, (prohance multipack), per ml
- A9578 – Injection, gadobenate dimeglumine (multihance multipack), per ml
- A9579 – Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml
- A9580 – Sodium fluoride f-18, diagnostic, per study dose, up to 30 millicuries
- A9581 – Injection, gadoxetate disodium, 1 ml
- A9582 – Iodine i-123 iobenguane, diagnostic, per study dose, up to 15 millicuries
- A9583 – Injection, gadofosveset trisodium, 1 ml
- A9584 – Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries
- A9585 – Injection, gadobutrol, 0.1 ml
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.